AlfonsoVicenteSuarez's Top Recommendations

These recommendations were last updated about an hour ago.

	Mouse and human dendritic cell subtypes [My Copy] Nat Rev Immunol, Vol. 2, No. 3. (March 2002), pp. 151-161. by Ken Shortman, Yong-Jun Liu posted by 2 people haeuslein devender
	Dendritic cells and the control of immunity [My Copy] Nature, Vol. 392, No. 6673. (19 March 1998), pp. 245-252. by Jacques Banchereau, Ralph M. Steinman posted by 4 people mariasommer haeuslein devender FlowCytometry
	Developmental pathways of dendritic cells in vivo: distinct function, phenotype, and localization of dendritic cell subsets in FLT3 ligand-treated mice. [My Copy] Journal of immunology (Baltimore, Md. : 1950), Vol. 159, No. 5. (1 September 1997), pp. 2222-2231. by B. Pulendran, J. Lingappa, M. K. Kennedy, et al.J. Smith, M. Teepe, A. Rudensky, C. R. Maliszewski, E. Maraskovsky posted by 2 people joberbloebaum shimi002
	Lymphatic drainage function and its immunological implications: from dendritic cell homing to vaccine design. [My Copy] Seminars in immunology In Innate and Adaptive Immune Responses in Tissue Engineering, Vol. 20, No. 2. (April 2008), pp. 147-156. by Melody A. Swartz, Jeffrey A. Hubbell, Sai T. Reddy posted by 1 person shimi002
	In Situ Imaging of the Endogenous CD8 T Cell Response to Infection [My Copy] Science, Vol. 318, No. 5847. (5 October 2007), pp. 116-120. by Kamal M. Khanna, Jeffery T. Mcnamara, Leo Lefrancois posted by 2 people shimi002 devender
	TLR Triggering on Tolerogenic Dendritic Cells Results in TLR2 Up-Regulation and a Reduced Proinflammatory Immune Program [My Copy] J Immunol, Vol. 183, No. 5. (1 September 2009), pp. 2984-2994. by Sonia Chamorro, Juan J. Garcia-Vallejo, Wendy W. J. Unger, et al.Rosette J. Fernandes, Sven C. M. Bruijns, Sandra Laban, Bart O. Roep, Bert A. 'T Hart, Yvette van Kooyk posted by 1 person dalia
	Paricalcitol (19-nor-1,25-dihydroxyvitamin D2) and calcitriol (1,25-dihydroxyvitamin D3) exert potent immunomodulatory effects on dendritic cells and inhibit induction of antigen-specific T cells [My Copy] Clinical Immunology (05 August 2009) by Klára Sochorová, Vít Budinský, Daniela Rožková, et al.Zuzana Tobiasová, Sylvie Dusilová-Sulková, Radek Špíšek, Jiřina Bartůňková posted by 1 person dalia
	IDO Activates Regulatory T Cells and Blocks Their Conversion into Th17-Like T Cells [My Copy] J Immunol, Vol. 183, No. 4. (15 August 2009), pp. 2475-2483. by Babak Baban, Phillip R. Chandler, Madhav D. Sharma, et al.Jeanene Pihkala, Pandelakis A. Koni, David H. Munn, Andrew L. Mellor posted by 3 people ashkelon13 dalia leliavski
	Induction of a non-encephalitogenic type 2 T helper-cell autoimmune response in multiple sclerosis after administration of an altered peptide ligand in a placebo-controlled, randomized phase II trial. The Altered Peptide Ligand in Relapsing MS Study Group. [My Copy] Nature medicine, Vol. 6, No. 10. (October 2000), pp. 1176-1182. by L. Kappos, G. Comi, H. Panitch, et al.J. Oger, J. Antel, P. Conlon, L. Steinman posted by 1 person dalia
	Treatment of multiple sclerosis with T-cell receptor peptides: results of a double-blind pilot trial. [My Copy] Nature medicine, Vol. 2, No. 10. (October 1996), pp. 1109-1115. by A. A. Vandenbark, Y. K. Chou, R. Whitham, et al.M. Mass, A. Buenafe, D. Liefeld, D. Kavanagh, S. Cooper, G. A. Hashim, H. Offner posted by 1 person dalia
	Prevention and treatment of murine experimental allergic encephalomyelitis with T cell receptor V beta-specific antibodies. [My Copy] The Journal of experimental medicine, Vol. 171, No. 6. (1 June 1990), pp. 1943-1955. by D. M. Zaller, G. Osman, O. Kanagawa, L. Hood posted by 1 person dalia
	T cell vaccination in multiple sclerosis patients with autologous CSF-derived activated T cells: results from a pilot study. [My Copy] Clinical and experimental immunology, Vol. 131, No. 1. (January 2003), pp. 155-168. by A. Van der Aa, N. Hellings, R. Medaer, et al.G. Gelin, Y. Palmers, J. Raus, P. Stinissen posted by 1 person dalia
	Vaccination against autoimmune encephalomyelitis with T-lymphocyte line cells reactive against myelin basic protein. [My Copy] Nature, Vol. 292, No. 5818. (2 July 1981), pp. 60-61. by A. Ben-Nun, H. Wekerle, I. R. Cohen posted by 1 person dalia
	Antigen-specific therapies in MS - Current concepts and novel approaches. [My Copy] Journal of the neurological sciences, Vol. 274, No. 1-2. (15 November 2008), pp. 18-22. by A. Lutterotti, M. Sospedra, R. Martin posted by 1 person dalia
	Induction of antigen-specific tolerance in multiple sclerosis after immunization with DNA encoding myelin basic protein in a randomized, placebo-controlled phase 1/2 trial. [My Copy] Archives of neurology, Vol. 64, No. 10. (October 2007), pp. 1407-1415. by A. Bar-Or, T. Vollmer, J. Antel, et al.D. L. Arnold, C. A. Bodner, D. Campagnolo, J. Gianettoni, F. Jalili, N. Kachuck, Y. Lapierre, M. Niino, J. Oger, M. Price, S. Rhodes, W. H. Robinson, F. D. Shi, P. J. Utz, F. Valone, L. Weiner, L. Steinman, H. Garren posted by 1 person dalia
	Induction of experimental autoimmune encephalomyelitis by CD4+ T cells specific for an astrocyte protein, S100 beta. [My Copy] Journal of neural transmission. Supplementum, Vol. 49 (1997), pp. 43-51. by K. Kojima, H. Wekerle, H. Lassmann, T. Berger, C. Linington posted by 1 person dalia
	The T Lymphocyte in Experimental Allergic Encephalomyelitis [My Copy] Annual Review of Immunology, Vol. 8, No. 1. (1990), pp. 579-621. by S. S. Zamvil, L. Steinman posted by 1 person dalia
	Immunological Aspects of Demyelinating Diseases [My Copy] Annual Review of Immunology, Vol. 10, No. 1. (1992), pp. 153-187. by Roland Martin, Henry F. Mcfarland, Dale E. Mcfarlin posted by 1 person dalia
	Dendritic cells for active immunotherapy: optimizing design and manufacture in order to develop commercially and clinically viable products. [My Copy] Vaccine, Vol. 25 Suppl 2 (27 September 2007) by C. A. Nicolette, D. Healey, I. Tcherepanova, et al.P. Whelton, T. Monesmith, L. Coombs, L. H. Finke, T. Whiteside, F. Miesowicz posted by 1 person dalia
	Large-scale generation of mature monocyte-derived dendritic cells for clinical application in cell factories. [My Copy] Journal of immunological methods, Vol. 268, No. 2. (15 October 2002), pp. 131-140. by T. G. Berger, B. Feuerstein, E. Strasser, et al.U. Hirsch, D. Schreiner, G. Schuler, B. Schuler-Thurner posted by 1 person dalia
	Generation of large numbers of fully mature and stable dendritic cells from leukapheresis products for clinical application. [My Copy] Journal of immunological methods, Vol. 223, No. 1. (1 February 1999), pp. 1-15. by B. Thurner, C. Röder, D. Dieckmann, et al.M. Heuer, M. Kruse, A. Glaser, P. Keikavoussi, E. Kämpgen, A. Bender, G. Schuler posted by 1 person dalia
	Repetitive injections of dendritic cells matured with tumor necrosis factor alpha induce antigen-specific protection of mice from autoimmunity. [My Copy] The Journal of experimental medicine, Vol. 195, No. 1. (7 January 2002), pp. 15-21. by M. Menges, S. Rössner, C. Voigtländer, et al.H. Schindler, N. A. Kukutsch, C. Bogdan, K. Erb, G. Schuler, M. B. Lutz posted by 1 person dalia
	Immature, semi-mature and fully mature dendritic cells: which signals induce tolerance or immunity? [My Copy] Trends in immunology, Vol. 23, No. 9. (September 2002), pp. 445-449. by M. B. Lutz, G. Schuler posted by 1 person dalia
	Mitomycin C-treated dendritic cells inactivate autoreactive T cells: toward the development of a tolerogenic vaccine in autoimmune diseases. [My Copy] Proceedings of the National Academy of Sciences of the United States of America, Vol. 105, No. 47. (25 November 2008), pp. 18442-18447. by P. Terness, T. Oelert, S. Ehser, et al.J. J. Chuang, I. Lahdou, C. Kleist, F. Velten, G. J. Hämmerling, B. Arnold, G. Opelz posted by 1 person dalia
	Dendritic CellsSpecialized and Regulated Antigen Processing Machines [My Copy] Cell, Vol. 106, No. 3. (10 August 2001), pp. 255-258. by Ira Mellman, Ralph M. Steinman posted by 1 person dalia
	Competition-based cellular peptide binding assays for 13 prevalent HLA class I alleles using fluorescein-labeled synthetic peptides [My Copy] Human Immunology, Vol. 64, No. 2. (February 2003), pp. 245-255. by J. Kessler posted by 1 person dalia
	Increased IL-23 secretion and altered chemokine production by dendritic cells upon CD46 activation in patients with multiple sclerosis. [My Copy] Journal of neuroimmunology, Vol. 195, No. 1-2. (March 2008), pp. 140-145. by A. Vaknin-Dembinsky, G. Murugaiyan, D. A. Hafler, A. L. Astier, H. L. Weiner posted by 1 person dalia
	Dendritic Cells in Immunity and Tolerance—Do They Display Opposite Functions? [My Copy] Immunity, Vol. 19, No. 1. (July 2003), pp. 5-8. by Muriel Moser posted by 1 person dalia
	Modern multiple sclerosis treatment - what is approved, what is on the horizon. [My Copy] Drug discovery today, Vol. 13, No. 23-24. (December 2008), pp. 1013-1025. by G. Pilz, P. Wipfler, G. Ladurner, J. Kraus posted by 1 person dalia
	Optimized culture conditions for the generation of dendritic cells from peripheral blood monocytes. [My Copy] Vox sanguinis, Vol. 84, No. 3. (April 2003), pp. 228-236. by A. Moldenhauer, M. M. Nociari, S. Dias, P. Lalezari, M. A. Moore posted by 1 person dalia
	Monocyte-derived dendritic cells as antigen-presenting cells in T-cell proliferation and cytokine production. [My Copy] Methods in molecular medicine, Vol. 138 (2008), pp. 97-106. by S. S. Sung posted by 1 person dalia
	Development of a standardized protocol for reproducible generation of matured monocyte-derived dendritic cells suitable for clinical application. [My Copy] Cytotechnology, Vol. 42, No. 3. (September 2003), pp. 121-131. by H. R. Bohnenkamp, T. Noll posted by 1 person dalia
	Prevention of type 1 diabetes by immature dendritic cells treated with an ethanol extract of Paecilomyces hepiali Chen mycelium. [My Copy] Methods and findings in experimental and clinical pharmacology, Vol. 30, No. 6. (g 2008), pp. 421-429. by C. Zhang, X. Zou, G. Leluo, J. Xu, M. Xiang posted by 1 person dalia
	Immunomodulation by mesenchymal stem cells: a potential therapeutic strategy for type 1 diabetes. [My Copy] Diabetes, Vol. 57, No. 7. (July 2008), pp. 1759-1767. by R. Abdi, P. Fiorina, C. N. Adra, M. Atkinson, M. H. Sayegh posted by 1 person dalia
	Production of a dendritic cell-based vaccine containing inactivated autologous virus for therapy of patients with chronic human immunodeficiency virus type 1 infection. [My Copy] Clinical and vaccine immunology : CVI, Vol. 16, No. 2. (February 2009), pp. 233-240. by T. L. Whiteside, P. Piazza, A. Reiter, et al.J. Stanson, N. C. Connolly, C. R. Rinaldo, S. A. Riddler posted by 1 person dalia
	Therapeutic immunization with dendritic cells loaded with heat-inactivated autologous HIV-1 in patients with chronic HIV-1 infection. [My Copy] The Journal of infectious diseases, Vol. 191, No. 10. (15 May 2005), pp. 1680-1685. by F. García, M. Lejeune, N. Climent, et al.C. Gil, J. Alcamí, V. Morente, L. Alós, A. Ruiz, J. Setoain, E. Fumero, P. Castro, A. López, A. Cruceta, C. Piera, E. Florence, A. Pereira, A. Libois, N. González, M. Guilá, M. Caballero, F. Lomeña, J. Joseph, J. M. Miró, T. Pumarola, M. Plana, J. M. Gatell, T. Gallart posted by 1 person dalia
	Phase II trial of dendritic cells loaded with antigens from self-renewing, proliferating autologous tumor cells as patient-specific antitumor vaccines in patients with metastatic melanoma: final report. [My Copy] Cancer biotherapy & radiopharmaceuticals, Vol. 24, No. 3. (June 2009), pp. 311-319. by R. O. Dillman, S. R. Selvan, P. M. Schiltz, et al.E. F. McClay, N. M. Barth, C. DePriest, C. de Leon, C. Mayorga, A. N. Cornforth, K. Allen posted by 1 person dalia
	Differential regulation of naïve and memory CD4+ T cells by alternatively activated dendritic cells. [My Copy] Journal of leukocyte biology, Vol. 84, No. 1. (July 2008), pp. 124-133. by A. E. Anderson, B. L. Sayers, M. A. Haniffa, et al.D. J. Swan, J. Diboll, X. N. Wang, J. D. Isaacs, C. M. Hilkens posted by 1 person dalia
	Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. [My Copy] The Journal of experimental medicine, Vol. 179, No. 4. (1 April 1994), pp. 1109-1118. by F. Sallusto, A. Lanzavecchia posted by 1 person dalia
	High immunogenicity of intracellular myelin oligodendrocyte glycoprotein epitopes. [My Copy] Journal of immunology (Baltimore, Md. : 1950), Vol. 169, No. 1. (1 July 2002), pp. 548-556. by R. Weissert, J. Kuhle, K. L. de Graaf, et al.W. Wienhold, M. M. Herrmann, C. Müller, T. G. Forsthuber, K. H. Wiesmüller, A. Melms posted by 1 person dalia
	Identification of a novel T cell epitope of human proteolipid protein (residues 40-60) recognized by proliferative and cytolytic CD4+ T cells from multiple sclerosis patients. [My Copy] Journal of neuroimmunology, Vol. 46, No. 1-2. (July 1993), pp. 33-42. by C. M. Pelfrey, J. L. Trotter, L. R. Tranquill, H. F. McFarland posted by 1 person dalia
	Human leukocyte antigen studies in multiple sclerosis. [My Copy] Annals of neurology, Vol. 36 Suppl (1994) by J. Hillert posted by 1 person dalia
	Multiple sclerosis in time and space--geographic clues to cause. [My Copy] Journal of neurovirology, Vol. 6 Suppl 2 (May 2000) by J. F. Kurtzke posted by 1 person dalia
	Genetic basis for clinical expression in multiple sclerosis. [My Copy] Brain : a journal of neurology, Vol. 125, No. Pt 1. (January 2002), pp. 150-158. by L. F. Barcellos, J. R. Oksenberg, A. J. Green, et al.P. Bucher, J. B. Rimmler, S. Schmidt, M. E. Garcia, R. R. Lincoln, M. A. Pericak-Vance, J. L. Haines, S. L. Hauser, posted by 1 person dalia
	Differential regulation by dexamethasone and cyclosporine of human T cells activated by various stimuli. [My Copy] Transplantation, Vol. 52, No. 3. (September 1991), pp. 522-526. by M. Furue, Y. Ishibashi posted by 1 person dalia
	The immunosuppressive macrolides FK-506 and rapamycin act as reciprocal antagonists in murine T cells. [My Copy] Journal of immunology (Baltimore, Md. : 1950), Vol. 144, No. 4. (15 February 1990), pp. 1418-1424. by F. J. Dumont, M. R. Melino, M. J. Staruch, S. L. Koprak, P. A. Fischer, N. H. Sigal posted by 1 person dalia
	Dendritic cell-expanded, islet-specific CD4+ CD25+ CD62L+ regulatory T cells restore normoglycemia in diabetic NOD mice. [My Copy] The Journal of experimental medicine, Vol. 204, No. 1. (22 January 2007), pp. 191-201. by K. V. Tarbell, L. Petit, X. Zuo, et al.P. Toy, X. Luo, A. Mqadmi, H. Yang, M. Suthanthiran, S. Mojsov, R. M. Steinman posted by 1 person dalia
	Monocyte-derived dendritic cells formed at the infection site control the induction of protective T helper 1 responses against Leishmania. [My Copy] Immunity, Vol. 26, No. 4. (April 2007), pp. 519-531. by B. León, M. López-Bravo, C. Ardavín posted by 1 person dalia
	Human dendritic cells: potent antigen-presenting cells at the crossroads of innate and adaptive immunity. [My Copy] Journal of immunology (Baltimore, Md. : 1950), Vol. 175, No. 3. (1 August 2005), pp. 1373-1381. by M. Rossi, J. W. Young posted by 1 person dalia
	In vitro generation of dendritic cells from human blood monocytes in experimental conditions compatible for in vivo cell therapy. [My Copy] Journal of hematotherapy & stem cell research, Vol. 9, No. 2. (April 2000), pp. 183-194. by H. Cao, V. Vergé, C. Baron, et al.C. Martinache, A. Leon, S. Scholl, N. C. Gorin, J. Salamero, S. Assari, J. Bernard, M. Lopez posted by 1 person dalia
	Dendritic cell subsets and lineages, and their functions in innate and adaptive immunity. [My Copy] Cell, Vol. 106, No. 3. (10 August 2001), pp. 259-262. by Y. J. Liu posted by 1 person dalia
	Dendritic cells as a tool to induce anergic and regulatory T cells. [My Copy] Trends in immunology, Vol. 22, No. 7. (July 2001), pp. 394-400. by H. Jonuleit, E. Schmitt, K. Steinbrink, A. H. Enk posted by 1 person dalia
	IL-17 and Th17 Cells. [My Copy] Annual review of immunology, Vol. 27 (2009), pp. 485-517. by T. Korn, E. Bettelli, M. Oukka, V. K. Kuchroo posted by 1 person dalia
	Dendritic cell regulation of TH1-TH2 development. [My Copy] Nature immunology, Vol. 1, No. 3. (September 2000), pp. 199-205. by M. Moser, K. M. Murphy posted by 1 person dalia
	Tolerogenic dendritic cells in health and disease: friend and foe! [My Copy] European journal of dermatology : EJD, Vol. 17, No. 6. (c 2007), pp. 476-491. by H. S. Adler, K. Steinbrink posted by 1 person dalia
	Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). [My Copy] Neurology, Vol. 33, No. 11. (November 1983), pp. 1444-1452. by J. F. Kurtzke posted by 1 person dalia
	Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. [My Copy] Neurology, Vol. 46, No. 4. (April 1996), pp. 907-911. by F. D. Lublin, S. C. Reingold posted by 1 person dalia
	Expansion and Functional Relevance of High-Avidity Myelin-Specific CD4+ T Cells in Multiple Sclerosis [My Copy] J Immunol, Vol. 172, No. 6. (15 March 2004), pp. 3893-3904. by Bibiana Bielekova, Myong-Hee Sung, Nadja Kadom, Richard Simon, Henry Mcfarland, Roland Martin posted by 1 person dalia
	Multi-peptide coupled-cell tolerance ameliorates ongoing relapsing EAE associated with multiple pathogenic autoreactivities☆ [My Copy] Journal of Autoimmunity, Vol. 27, No. 4. (December 2006), pp. 218-231. by C. Smith, S. Miller posted by 1 person dalia
	Autoimmune concepts of multiple sclerosis as a basis for selective immunotherapy: from pipe dreams to (therapeutic) pipelines. [My Copy] Proceedings of the National Academy of Sciences of the United States of America, Vol. 101 Suppl 2 (5 October 2004), pp. 14599-14606. by R. Hohlfeld, H. Wekerle posted by 1 person dalia
	The challenge of multiple sclerosis: how do we cure a chronic heterogeneous disease? [My Copy] Annals of neurology, Vol. 65, No. 3. (March 2009), pp. 239-248. by H. L. Weiner posted by 1 person dalia
	Phenotypic and functional markers for 1α,25-dihydroxyvitamin D<sub>3</sub>-modified regulatory dendritic cells [My Copy] Clinical & Experimental Immunology, Vol. 157, No. 1. (2009), pp. 48-59. by A. W. Pedersen, K. Holmstrøm, S. S. Jensen, et al.D. Fuchs, S. Rasmussen, P. Kvistborg, M. H. Claesson, M. B. Zocca posted by 1 person dalia
	EBV in MS: guilty by association? [My Copy] Trends in Immunology, Vol. 30, No. 6. (08 June 2009), pp. 243-248. by Jan D. Lünemann, Christian Münz posted by 1 person dalia
	Myelin peptides in multiple sclerosis☆ [My Copy] Autoimmunity Reviews, Vol. 8, No. 8. (12 July 2009), pp. 650-653. by L. Grau-López, D. Raïch, C. Ramo-Tello, et al.M. Naranjo-Gómez, A. Dàvalos, R. Pujol-Borrell, F. E. Borràs, E. Martínez-Cáceres posted by 1 person dalia
	Recent clinical trials and future therapies [My Copy] Journal of Neurology, Vol. 255, No. 6. (1 December 2008), pp. 93-96. by Sven Meuth, Christoph Kleinschnitz, Heinz Wiendl posted by 1 person dalia
	Effect of ex vivo culture duration on phenotype and cytokine production by mature dendritic cells derived from peripheral blood monocytes [My Copy] Transfusion, Vol. 49, No. 3., pp. 536-547. by Abdul Tawab, Yong Fan, Elizabeth J. Read, Roger J. Kurlander posted by 1 person dalia
	Manipulating dendritic cell biology for the active immunotherapy of cancer [My Copy] Blood, Vol. 104, No. 8. (15 October 2004), pp. 2235-2246. by David W. O'Neill, Sylvia Adams, Nina Bhardwaj posted by 2 people dalia srp33
	Alemtuzumab vs. Interferon Beta-1a in Early Multiple Sclerosis [My Copy] N Engl J Med, Vol. 359, No. 17. (23 October 2008), pp. 1786-1801. by The posted by 2 people dalia nguizard
	Are indoleamine-2,3-dioxygenase producing human dendritic cells a tool for suppression of allogeneic T-cell responses? [My Copy] Transplantation, Vol. 83, No. 4. (27 February 2007), pp. 468-473. by S. Löb, S. Ebner, S. Wagner, J. Weinreich, R. Schäfer, A. Königsrainer
	Indoleamine 2,3-dioxygenase production by human dendritic cells results in the inhibition of T cell proliferation. [My Copy] Journal of immunology (Baltimore, Md. : 1950), Vol. 164, No. 7. (1 April 2000), pp. 3596-3599. by P. Hwu, M. X. Du, R. Lapointe, M. Do, M. W. Taylor, H. A. Young posted by 1 person dalia
	A CENTRAL ROLE FOR CENTRAL TOLERANCE [My Copy] Annual Review of Immunology, Vol. 24, No. 1. (2006), pp. 571-606. by Bruno Kyewski, Ludger Klein posted by 2 people dalia eisei
	Antigen-bearing immature dendritic cells induce peptide-specific CD8(+) regulatory T cells in vivo in humans. [My Copy] Blood, Vol. 100, No. 1. (1 July 2002), pp. 174-177. by M. V. Dhodapkar, R. M. Steinman posted by 1 person dalia
	Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells. [My Copy] J Exp Med, Vol. 193, No. 2. (15 January 2001), pp. 233-238. by M. V. Dhodapkar, R. M. Steinman, J. Krasovsky, C. Munz, N. Bhardwaj posted by 1 person dalia
	Regulatory conversation between antigen presenting cells and regulatory T cells enhance immune suppression. [My Copy] Cell Immunol (28 February 2008) by Karsten Mahnke, Tanja Bedke, Alexander H H. Enk posted by 1 person dalia
	Infusion of stably immature monocyte-derived dendritic cells plus CTLA4Ig modulates alloimmune reactivity in rhesus macaques. [My Copy] Transplantation, Vol. 84, No. 2. (27 July 2007), pp. 196-206. by A. F. Zahorchak, L. S. Kean, D. Tokita, et al.H. R. Turnquist, M. Abe, J. Finke, K. Hamby, M. R. Rigby, C. P. Larsen, A. W. Thomson posted by 1 person dalia
	1 Alpha,25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation. [My Copy] J Immunol, Vol. 164, No. 5. (1 March 2000), pp. 2405-2411. by G. Penna, L. Adorini posted by 1 person dalia
	Vitamin D3 affects differentiation, maturation, and function of human monocyte-derived dendritic cells. [My Copy] J Immunol, Vol. 164, No. 9. (1 May 2000), pp. 4443-4451. by L. Piemonti, P. Monti, M. Sironi, et al.P. Fraticelli, B. E. Leone, E. Dal Cin, P. Allavena, V. Di Carlo posted by 1 person dalia
	Vitamin D3-mediated alterations to myeloid dendritic cell trafficking in vivo expand the scope of their antigen presenting properties. [My Copy] Vaccine, Vol. 25, No. 7. (26 January 2007), pp. 1236-1249. by E. Y. Enioutina, D. Bareyan, R. A. Daynes posted by 1 person dalia
	Autoimmune inflammation from the Th17 perspective [My Copy] Autoimmunity Reviews, Vol. 6, No. 3. (January 2007), pp. 169-175. by J. Furuzawacarballeda, M. Vargasrojas, A. Cabral posted by 2 people dalia immuno08
	Tolerogenic dendritic cells and the quest for transplant tolerance [My Copy] Nature Reviews Immunology, Vol. 7, No. 8. (13 July 2007), pp. 610-621. by Adrian E. Morelli, Angus W. Thomson posted by 3 people dalia f299 mgh-lcs
	Granulocyte-macrophage colony-stimulating factor drives monocytes to CD14low CD83+ DCSIGN- interleukin-10-producing myeloid cells with differential effects on T-cell subsets. [My Copy] Immunology, Vol. 121, No. 4. (August 2007), pp. 499-507. by D. Ganguly, K. Paul, J. Bagchi, et al.S. Rakshit, L. Mandal, G. Bandyopadhyay, S. Bandyopadhyay posted by 1 person dalia
	Phenotype and in vitro function of mature MDDC generated from cryopreserved PBMC of cancer patients are equivalent to those from healthy donors [My Copy] Journal of Immune Based Therapies and Vaccines, Vol. 5 (03 May 2007), 7. by Smita A. Ghanekar, Sonny Bhatia, Joyce J. Ruitenberg, et al.Corazon D. Rosa, Mary L. Disis, Vernon C. Maino, Holden T. Maecker, Cory A. Waters posted by 1 person dalia
	Steady-state and inflammatory dendritic-cell development. [My Copy] Nature reviews. Immunology, Vol. 7, No. 1. (15 January 2007), pp. 19-30. by K. Shortman, S. H. Naik posted by 1 person dalia
	The danger model: a renewed sense of self. [My Copy] Science, Vol. 296, No. 5566. (12 April 2002), pp. 301-305. by P. Matzinger posted by 3 people dalia sfedson tomhebbron
	Human Immature Dendritic Cells Efficiently Bind and Take up Secretory IgA Without the Induction of Maturation [My Copy] J Immunol, Vol. 168, No. 1. (1 January 2002), pp. 102-107. by Heleen C. Heystek, Corinne Moulon, Andrea M. Woltman, Pierre Garonne, Cees van Kooten posted by 1 person haeuslein
	Enzyme-linked immunosorbent assay (ELISA). Quantitative assay of immunoglobulin G. [My Copy] Immunochemistry, Vol. 8, No. 9. (September 1971), pp. 871-874. by E. Engvall, P. Perlmann posted by 1 person haeuslein
	A method for quantitative determination of cellular immunoglobulins by enzyme-labeled antibodies. [My Copy] European journal of immunology, Vol. 1, No. 5. (November 1971), pp. 394-396. by S. Avrameas, B. Guilbert posted by 1 person haeuslein
	Establishment and characterization of a human acute monocytic leukemia cell line (THP-1). [My Copy] International journal of cancer. Journal international du cancer, Vol. 26, No. 2. (August 1980), pp. 171-176. by S. Tsuchiya, M. Yamabe, Y. Yamaguchi, Y. Kobayashi, T. Konno, K. Tada posted by 1 person haeuslein
	CLONAL GROWTH OF MAMMALIAN CELLS IN A CHEMICALLY DEFINED, SYNTHETIC MEDIUM. [My Copy] Proceedings of the National Academy of Sciences of the United States of America, Vol. 53 (February 1965), pp. 288-293. by R. G. HAM posted by 1 person haeuslein
	Differentiation between attached and ingested immune complexes by a fluorescence quenching cytofluorometric assay. [My Copy] Journal of immunological methods, Vol. 60, No. 1-2. (27 May 1983), pp. 115-124. by S. Sahlin, J. Hed, I. Rundquist posted by 1 person haeuslein
	Pulmonary surfactant proteins A and D enhance neutrophil uptake of bacteria [My Copy] Am J Physiol Lung Cell Mol Physiol, Vol. 274, No. 6. (1 June 1998), pp. L958-969. by Kevan L. Hartshorn, Erika Crouch, Mitchell R. White, et al.Maria L. Colamussi, Anand Kakkanatt, Benjamin Tauber, Virginia Shepherd, Kedarnath N. Sastry posted by 1 person haeuslein
	Fc alpha-receptor expression on the myelomonocytic cell line THP-1: comparison with human alveolar macrophages. [My Copy] The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology, Vol. 7, No. 6. (June 1994), pp. 1111-1119. by Y. Sibille, S. Depelchin, P. Staquet, et al.B. Chatelain, P. Coulie, L. Shen, C. Vander Maelen, J. P. Vaerman posted by 1 person haeuslein
	Changes in IgG Fc receptor expression induced by phorbol 12-myristate 13-acetate treatment of THP-1 monocytic leukemia cells. [My Copy] Leukemia research, Vol. 16, No. 3. (1992), pp. 317-327. by J. Auwerx, B. Staels, F. Van Vaeck, J. L. Ceuppens posted by 1 person haeuslein
	The Glycosylation and Structure of Human Serum IgA1, Fab, and Fc Regions and the Role of N-Glycosylation on Fcalpha Receptor Interactions [My Copy] J. Biol. Chem., Vol. 273, No. 4. (23 January 1998), pp. 2260-2272. by Taj S. Mattu, Richard J. Pleass, Antony C. Willis, et al.Mogens Kilian, Mark R. Wormald, Annemarie C. Lellouch, Pauline M. Rudd, Jenny M. Woof, Raymond A. Dwek posted by 1 person haeuslein
	Regulated Expression of the Pathogen Receptor Dendritic Cell-specific Intercellular Adhesion Molecule 3 (ICAM-3)-grabbing Nonintegrin in THP-1 Human Leukemic Cells, Monocytes, and Macrophages [My Copy] J. Biol. Chem., Vol. 279, No. 24. (11 June 2004), pp. 25680-25688. by Amaya Puig-Kroger, Diego Serrano-Gomez, Esther Caparros, et al.Angeles Dominguez-Soto, Miguel Relloso, Maria Colmenares, Laura Martinez-Munoz, Natividad Longo, Noelia Sanchez-Sanchez, Mercedes Rincon, Luis Rivas, Paloma Sanchez-Mateos, Elena Fernandez-Ruiz, Angel L. Corbi posted by 1 person haeuslein
	Proliferating dendritic cell progenitors in human blood. [My Copy] The Journal of experimental medicine, Vol. 180, No. 1. (1 July 1994), pp. 83-93. by N. Romani, S. Gruner, D. Brang, et al.E. Kämpgen, A. Lenz, B. Trockenbacher, G. Konwalinka, P. O. Fritsch, R. M. Steinman, G. Schuler posted by 1 person haeuslein
	Induction of Maturation in Cultured Human Monocytic Leukemia Cells by a Phorbol Diester [My Copy] Cancer Res, Vol. 42, No. 4. (1 April 1982), pp. 1530-1536. by Shigeru Tsuchiya, Yasuko Kobayashi, Yoichi Goto, et al.Hidesada Okumura, Shingi Nakae, Tasuke Konno, Keiya Tada posted by 1 person haeuslein
	Extensive Repertoire of Membrane-bound and Soluble Dendritic Cell-specific ICAM-3-grabbing Nonintegrin 1 (DC-SIGN1) and DC-SIGN2 Isoforms. INTER-INDIVIDUAL VARIATION IN EXPRESSION OF DC-SIGN TRANSCRIPTS [My Copy] J. Biol. Chem., Vol. 276, No. 35. (24 August 2001), pp. 33196-33212. by Srinivas Mummidi, Gabriel Catano, Leeann Lam, et al.Angelina Hoefle, Vanessa Telles, Kazi Begum, Fabio Jimenez, Seema S. Ahuja, Sunil K. Ahuja posted by 1 person haeuslein
	DC-SIGN (CD209) expression is IL-4 dependent and is negatively regulated by IFN, TGF-beta, and anti-inflammatory agents. [My Copy] Journal of immunology (Baltimore, Md. : 1950), Vol. 168, No. 6. (15 March 2002), pp. 2634-2643. by M. Relloso, A. Puig-Kröger, O. M. Pello, et al.J. L. Rodríguez-Fernández, G. de la Rosa, N. Longo, J. Navarro, M. A. Muñoz-Fernández, P. Sánchez-Mateos, A. L. Corbí posted by 1 person haeuslein
	Constitutive and induced expression of DC-SIGN on dendritic cell and macrophage subpopulations in situ and in vitro [My Copy] J Leukoc Biol, Vol. 71, No. 3. (1 March 2002), pp. 445-457. by Elizabeth J. Soilleux, Lesley S. Morris, George Leslie, et al.Jihed Chehimi, Qi Luo, Ernest Levroney, John Trowsdale, Luis J. Montaner, Robert W. Doms, Drew Weissman, Nicholas Coleman, Benhur Lee posted by 1 person haeuslein